Quibim, a company using imaging biomarkers for precision medicine, has added a new cancer detection capability to its prostate tool based on AI, QP-Prostate.
Colin Spellacy, head of sales, Rösler UK discusses how in the precision-driven realms of the medical industry, the roles of mass finishing and shot blasting technologies cannot be overstated.
Samantha Collins, partner and Marcela Carvalho, associate at IP firm Marks & Clerk, explain how due to so many femtech products being directed straight at consumers, as opposed to medical professionals, brand protection is particularly important.
Duncan Hand, director of the Medical Device Manufacturing Centre explains why an integrated ecosystem, combined with natural innovative spirit, are essential to the future of Scotland’s medical device manufacturing sector.
Anne Lepetit, chief medical officer, Bupa Group, explains how health technology is transforming mental health management and helping more people to hit their health goals in 2024.
Neil Curtis, DVP sales, marketing, and service, Zygo, shares opinion on the topic of women in engineering with women that have specialised in engineering related roles.
Jordan Amos, enterprise account executive, UK public sector specialist at LogicMonitor, discusses why health trusts need to prioritise the right technology to succeed with their digital transformation projects.
Could 2024 be the year that UK manufacturers finally embrace robotics? After trailing behind our international counterparts for years, FANUC UK discusses how the UK is now starting to catch up when it comes to the installation of industrial robotics.
Ryan Phelan, partner and registered patent attorney at Marshall, Gerstein & Borun, examines the intellectual property challenges involving artificial intelligence in the medical technology sector.
Has all investment in digital health been positive? Shameem C Hameed, founder and CEO of blueBriX, provides insight into industry advances, why he believes over investment is killing digital health and how the sector will evolve in 2024 and beyond.
